Genome Sequencing of Sewage Detects Regionally Prevalent SARS-CoV-2 Variants.

Crits-Christoph A, Kantor RS, Olm MR, Whitney ON, Al-Shayeb B, Lou YC, Flamholz A, Kennedy LC, Greenwald H, Hinkle A, Hetzel J, Spitzer S, Koble J, Tan A, Hyde F, Schroth G, Kuersten S, Banfield JF, Nelson KL. · 2021

Read Genome Sequencing of Sewage Detects Regionally Prevalent SARS-CoV-2 Variants. by Crits-Christoph A, Kantor RS, Olm MR, Whitney ON, Al-Shayeb B, Lou YC, Flamholz A, Kennedy LC, Greenwald H, Hinkle A, Hetzel J, Spitzer S, Koble J, Tan A, Hyde F, Schroth G, Kuersten S, Banfield JF, Nelson KL. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7845645.txt.

Introduction

Crits-Christoph and co-authors show that sewage sequencing can spot the SARS-CoV-2 variants in a region. Virus genomes are usually read from patient nose swabs. That route tracks spread one person at a time. Sewage gathers virus from a whole community at once.

The team sequenced virus genomes from sewage samples. The variants found matched those common in the area. Sewage thus gives a cheap picture of local viral diversity. It needs no testing of single patients. Changes in variant mix can be watched over time. The method suits places with thin clinical testing. It also adds an early warning layer for new variants.

Catalog record

CREATORCrits-Christoph A, Kantor RS, Olm MR, Whitney ON, Al-Shayeb B, Lou YC, Flamholz A, Kennedy LC, Greenwald H, Hinkle A, Hetzel J, Spitzer S, Koble J, Tan A, Hyde F, Schroth G, Kuersten S, Banfield JF, Nelson KL.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE37 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7845645

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Genome Sequencing of Sewage Detects Regionally Prevalent SARS-CoV-2 Variants By Alexander Crits-Christoph, Rose S. Kantor, Matthew R. Olm, Oscar N. Whitney, Basem Al-Shayeb, Yue Clare Lou, Avi Flamholz, Lauren C. Kennedy, Hannah Greenwald, Adrian Hinkle, Jonathan Hetzel, Sara Spitzer Published in: mBio DOI: 10.1128/mBio.02703-20 ABSTRACT Viral genome sequencing has guided our understanding of the spread and extent of genetic diversity of SARS-CoV-2 during the COVID-19 pandemic. SARS-CoV-2 viral genomes are usually sequenced from nasopharyngeal swabs of individual patients to track viral spread. INTRODUCTION The COVID-19 pandemic caused by SARS-CoV-2 reached the United States at the start of 2020, with multiple early introduction events in the states of Washington, California, and New York (1). Since then, the total number of cases in the country has surpassed 14 million, with over 275,000 deaths and enormous implications for public health (2). While clinical viral cases have been tracked mostly with quantitative reverse transcriptase PCR (RT-qPCR), there has also been extensive whole viral genome sequencing of clinical cases, generating over 75,000 genomes globally, including 17,000 from the United States and 2,500 from California (GISAID EpiCov database as of 23 August 2020) (3). Genomic epidemiology, the analysis of viral and microbial genomes in order to make inferences about pathogen evolution, transmission, and spread, has played an important role in improving our understanding of the transmission dynamics of the SARS-CoV-2 pandemic (4). Early in the pandemic, this approach revealed multiple introduction events into California and viral lineages present at different abundances across counties in Northern California (5). Genome sequencing was also used to show that there was unexpectedly frequent community spread of a specific genotype after early introduction in Washington State (6). Genome sequencing in the New York City area identified multiple viral introduction events from Europe (7), and sequencing in the Mission district of San Francisco identified distinct viral strains in a single neighborhood, with transmission between family clusters (8). Unlike many respiratory viruses, RNA of SARS-CoV-2 and other coronaviruses can be detected in human feces (9–11). Before the COVID-19 pandemic, members of the Coronaviridae had been previously identified in municipal wastewater through both RT-qPCR and shotgun metagenomic and metatranscriptomic sequencing (12, 13). Since the start of the COVID-19 pandemic, wastewater RT-qPCR has quantified the amount of SARS-CoV-2 RNA in sewage to estimate the abundance of the virus across many different municipal regions globally (14–22). Prior work showed that shotgun wastewater sequencing can provide information about many viruses simultaneously (12, 23, 24) and enable genome-resolved (25) and phylogenetic analyses (26, 27). In one study, a SARS-CoV-2 consensus genome was obtained from sewage via targeted amplification and long-read sequencing, allowing for phylogenetic analysis of the predominant lineage (27). Here, we show that sequencing of viral concentrates and RNA extracted directly from wastewater can identify multiple SARS-CoV-2 genotypes at various abundances known to be present in communities, as well as additional genotypic variants not yet observed in local clinical sequencing efforts. RESULTS AND DISCUSSION Metatranscriptomic detection of SARS-CoV-2 and other viruses in wastewater. Twenty-four-hour 1-liter composite samples of raw sewage were collected from wastewater treatment facilities in Alameda and Marin Counties in Northern California between 19 May 2020 and 15 July 2020 (see Table S1 in the supplemental material). We extracted nucleic acids from samples using three methods that enriched for viral particles (ultrafiltration) or total RNA (RNA silica columns or silica milk). SARS-CoV-2 viral RNA was first detected using a RT-qPCR assay (see Materials and Methods) of the N gene and Cq values ranged from 29.5 to 36.2, or an estimated ∼2 to ∼553 genome copies/μl of RNA. From this we estimate that there were 2.8 × 105 genome copies/liter of wastewater on average across our samples (see Table S1). For each sample, 40 to 50 μl of RNA was prepared for sequencing, implying an estimated ∼4,438 viral genome copies on average were contained within each sequencing library. 10.1128/mBio.02703-20.1TABLE S1Metadata for sequenced samples. Download Table S1, XLSX file, 0.01 MB.Copyright © 2021 Crits-Christoph et al.2021Crits-Christoph et al.This content is distributed under the terms of the Creative Commons Attribution 4.0 International license. After cDNA synthesis from the total RNA, samples were enriched for a panel of human respiratory viruses using a commercially available oligo-capture approach (Illumina respiratory virus panel; see Materials and Methods) and sequenced on a NextSeq 550 to produce on average 12 million 2 × 75 bp reads per sample. Reads were mapped to the human genome to estimate the amount of human RNA/DNA in the samples (0.7 to 16% of reads per sample). Sequencing reads were then mapped to a dereplicated set of all eukaryotic viruses contained in the RefSeq database, and stringently filtered to include only high-quality reads matching reference sequences with >97% identity (see Materials and Methods). Viral abundances and SNVs (single nucleotide variants) were then calculated using the metagenomic strain-typing program inStrain v1.12. We detected SARS-CoV-2 at various abundances of sequenced RNA/DNA (0 to 14%) across samples (Fig. 1a and b; see also Table S1). Sequencing relative abundance of SARS-CoV-2 was not strongly correlated with RT-qPCR genome copy quantification, likely due to the variability introduced by different extraction methods. Viral enrichment by ultrafiltration achieved higher relative abundances of SARS-CoV-2 RNA, although these experiments were time-intensive and often had lower absolute genome copy number recovery according to RT-qPCR. In addition, we sequenced replicates from one set of samples with rRNA depletion but no viral enrichment. Without enrichment, we were able to only detect fewer than 40 total SARS-CoV-2 read pairs (Fig. 1c; see also Table S1). While this illustrates the difficulty of detecting specific viruses in wastewater in unenriched sequencing data sets, larger sequencing efforts may overcome this limitation by sequencing more deeply. [Figure: Characterized viruses detected in enriched and unenriched wastewater metatranscriptomes. The relative abundances of viruses with eukaryotic hosts in the RefSeq database as a percentage of total sequencing reads derived from the sample in Amicon ultrafiltration (viral fractionation) (a) and total RNA column and milk of silica samples (b). All samples were enriched with the Illumina respiratory virus panel. (c) Relative abundances of RefSeq viruses in unenriched metatranscriptomics (left) and the same samples after oligonucleotide enrichment with the Illumina respiratory virus panel. (d) The relationship between the quantity of viral genome copies in 40 μl of purified RNA and SARS-CoV-2 genome completeness (measured in breadth of coverage) for each sample. Samples are colored by extraction methodology, and the size of the point corresponds to the mean SARS-CoV-2 depth of coverage.] Other human viruses identified in the wastewater sequencing included Human bocaviruses 2c and 3 (Fig. 1a and b), both of which are respiratory viruses sometimes capable of causing gastroenteritis, and are included in the Illumina respiratory virus panel. Bocaviruses have been identified in sewage samples previously (28, 29). Picornavirus-like viruses were also detected (Fig. 1c). The most abundant viruses in the data were plant viruses including cucumber green mottle mosaic virus and pepper mild mottle virus (PMMoV) (Fig. 1a). These viruses are known to be highly abundant in human wastewater (30) and have been used as fecal loading controls in wastewater SARS-CoV-2 quantification (19). Near-complete (>95% breadth of coverage) genomes were obtained for SARS-CoV-2, bocavirus 3, PMMoV, and other plant viruses (see Table S2), implying that these viruses were

Read the complete text